Rate Versus Rhythm Control for Atrial Fibrillation.
Edward D ShinH Nicole TranNirmala D RamalingamTaylor LiuEugene FanPublished in: The Permanente journal (2023)
Atrial fibrillation (AF) is an arrhythmia characterized by disorganized atrial activity with an associated unevenly irregular ventricular response on an electrocardiogram. It is the most common sustained arrhythmia, with a lifetime risk of 25% in patients older than 40 years old. The incidence of AF increases with age and is associated with an increased risk for heart failure, stroke, adverse cardiac events, and dementia. The 2 main aims of AF treatment include anticoagulation for thromboembolism prophylaxis as well as rate vs rhythm control. The focus of this article will be on the treatment strategies in managing AF. Rate control refers to the use of atrioventricular nodal blocking medications, including beta blockers and calcium channel blockers, to maintain a goal heart rate. Rhythm control, on the other hand, refers to a treatment strategy focused on the use of antiarrhythmic drugs (AAD), cardioversion, and ablation to restore and to maintain a patient in sinus rhythm. Currently, the ideal treatment strategy remains greatly debated. Thus, we hope to compare the risks and benefits of rate to rhythm control to highlight how patients with AF are managed here at Kaiser Permanente Northern California (KPNC).
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- heart failure
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- heart rate
- percutaneous coronary intervention
- heart rate variability
- left ventricular
- prognostic factors
- blood pressure
- venous thromboembolism
- angiotensin converting enzyme
- combination therapy
- lymph node
- physical activity
- blood brain barrier
- mitral valve
- angiotensin ii
- neoadjuvant chemotherapy
- community dwelling